Following FMN intervention, the activation of hypothalamic microglia, the proliferation of astrocytes, and the mRNA expression levels of inflammatory cytokines, as well as NF‐κB pathway‐related genes and proteins, were significantly reduced in MetS mice. The gene discussed is NFKB1; the disease is metabolic syndrome.